Literature DB >> 31113863

Control of p53-dependent transcription and enhancer activity by the p53 family member p63.

Gizem Karsli Uzunbas1, Faraz Ahmed1, Morgan A Sammons2.   

Abstract

Transcriptional activation by p53 provides powerful, organism-wide tumor suppression. We hypothesized that the local chromatin environment, including differential enhancer activities, contributes to various p53-dependent transcriptional activities in different cell types during stress-induced signaling. In this work, using ChIP-sequencing, immunoblotting, quantitative PCR, and computational analyses across various mammalian cell lines, we demonstrate that the p53-induced transcriptome varies by cell type, reflects cell type-specific activities, and is considerably broader than previously anticipated. We found that these molecular events are strongly influenced by p53's engagement with differentially active cell type-specific enhancers and promoters. We also observed that p53 activity depends on the p53 family member tumor protein p63 in epithelial cell types. Notably, we demonstrate that p63 is required for epithelial enhancer identity, including enhancers used by p53 during stress-dependent signaling. Loss of p63, but not p53, caused site-specific depletion of enhancer-associated chromatin modifications, suggesting that p63 functions as an enhancer maintenance factor in epithelial cells. Additionally, a subset of epithelial-specific enhancers depends on the activity of p63 providing a direct link between lineage determination and enhancer structure. These results suggest that a broad, cell-intrinsic mechanism controls p53-dependent cellular stress response through differential regulation of cis-regulatory elements.
© 2019 Karsli Uzunbas et al.

Entities:  

Keywords:  DNA damage response; chromatin; chromatin modification; chromatin regulation; epigenetics; p53; p63; transcription; transcription factor; transcription regulation

Mesh:

Substances:

Year:  2019        PMID: 31113863      PMCID: PMC6615668          DOI: 10.1074/jbc.RA119.007965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

1.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.

Authors:  A Yang; R Schweitzer; D Sun; M Kaghad; N Walker; R T Bronson; C Tabin; A Sharpe; D Caput; C Crum; F McKeon
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

2.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

Review 3.  The p63 gene in EEC and other syndromes.

Authors:  H G Brunner; B C J Hamel; H Van Bokhoven
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

4.  p63 is the molecular switch for initiation of an epithelial stratification program.

Authors:  Maranke I Koster; Soeun Kim; Alea A Mills; Francesco J DeMayo; Dennis R Roop
Journal:  Genes Dev       Date:  2004-01-16       Impact factor: 11.361

5.  p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage.

Authors:  Joaquín M Espinosa; Ramiro E Verdun; Beverly M Emerson
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

6.  Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells.

Authors:  Annie Yang; Zhou Zhu; Philipp Kapranov; Frank McKeon; George M Church; Thomas R Gingeras; Kevin Struhl
Journal:  Mol Cell       Date:  2006-11-17       Impact factor: 17.970

7.  p63 regulates an adhesion programme and cell survival in epithelial cells.

Authors:  Danielle K Carroll; Jason S Carroll; Chee-Onn Leong; Fang Cheng; Myles Brown; Alea A Mills; Joan S Brugge; Leif W Ellisen
Journal:  Nat Cell Biol       Date:  2006-05-21       Impact factor: 28.824

Review 8.  p53, p63 and p73--solos, alliances and feuds among family members.

Authors:  U M Moll; S Erster; A Zaika
Journal:  Biochim Biophys Acta       Date:  2001-12-28

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

Review 10.  The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; J Y Wang; G Melino
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  9 in total

1.  Locally acting transcription factors regulate p53-dependent cis-regulatory element activity.

Authors:  Allison N Catizone; Gizem Karsli Uzunbas; Petra Celadova; Sylvia Kuang; Daniel Bose; Morgan A Sammons
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

2.  Identification of universal and cell-type specific p53 DNA binding.

Authors:  Antonina Hafner; Lyubov Kublo; Michael Tsabar; Galit Lahav; Jacob Stewart-Ornstein
Journal:  BMC Mol Cell Biol       Date:  2020-02-18

3.  Increased p53 signaling impairs neural differentiation in HUWE1-promoted intellectual disabilities.

Authors:  Rossana Aprigliano; Merdane Ezgi Aksu; Stefano Bradamante; Boris Mihaljevic; Wei Wang; Kristin Rian; Nicola P Montaldo; Kayla Mae Grooms; Sarah L Fordyce Martin; Diana L Bordin; Matthias Bosshard; Yunhui Peng; Emil Alexov; Cindy Skinner; Nina-Beate Liabakk; Gareth J Sullivan; Magnar Bjørås; Charles E Schwartz; Barbara van Loon
Journal:  Cell Rep Med       Date:  2021-04-08

4.  ΔNp63 is a pioneer factor that binds inaccessible chromatin and elicits chromatin remodeling.

Authors:  Xinyang Yu; Prashant K Singh; Shamira Tabrejee; Satrajit Sinha; Michael J Buck
Journal:  Epigenetics Chromatin       Date:  2021-04-17       Impact factor: 4.954

5.  VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer.

Authors:  Jiahao Liu; Yinghao Wen; Zhen Liu; Shu Liu; Ping Xu; Yan Xu; Shuting Deng; Shulu Hu; Rongcheng Luo; Jingwen Jiang; Guifang Yu
Journal:  Mol Ther Nucleic Acids       Date:  2020-11-17       Impact factor: 8.886

6.  p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.

Authors:  Bradley D Weaver; Christina M Smith; Edward J Grow; Jingtao Guo; Paula Stein; Sean C Shadle; Peter G Hendrickson; Nicholas E Johnson; Russell J Butterfield; Roberta Menafra; Susan L Kloet; Silvère M van der Maarel; Carmen J Williams; Bradley R Cairns
Journal:  Nat Genet       Date:  2021-07-15       Impact factor: 38.330

7.  Transcription factor enrichment analysis (TFEA) quantifies the activity of multiple transcription factors from a single experiment.

Authors:  Jonathan D Rubin; Jacob T Stanley; Rutendo F Sigauke; Cecilia B Levandowski; Zachary L Maas; Jessica Westfall; Dylan J Taatjes; Robin D Dowell
Journal:  Commun Biol       Date:  2021-06-02

Review 8.  p63 and p53: Collaborative Partners or Dueling Rivals?

Authors:  Dana L Woodstock; Morgan A Sammons; Martin Fischer
Journal:  Front Cell Dev Biol       Date:  2021-07-05

9.  Tumor suppressor p53: from engaging DNA to target gene regulation.

Authors:  Morgan A Sammons; Thuy-Ai T Nguyen; Simon S McDade; Martin Fischer
Journal:  Nucleic Acids Res       Date:  2020-09-18       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.